Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ITOS | iTeos Therapeutics, Inc. | Gall Matthew | Chief Financial Officer | Oct 12, 2023 | Buy | $8.37 | 5,000 | 41,850 | 19,429 | Oct 12, 2023, 05:09 PM | |
ITOS | iTeos Therapeutics, Inc. | Gall Matthew | Chief Financial Officer | Dec 27, 2021 | Sale | $46.45 | 5,000 | 232,250 | 14,429 | Dec 28, 2021, 08:58 PM | |
ITOS | iTeos Therapeutics, Inc. | Gall Matthew | Chief Financial Officer | Oct 11, 2021 | Option Exercise | $6.16 | 14,429 | 88,883 | 19,429 | Oct 12, 2021, 08:02 PM |